Long-term outcomes after radiofrequency catheter ablation of paroxysmal and persistent atrial fibrillation
Abstract
Background: Short-term oucomes of radiofrequency (RF) catheter isolation of the pulmonary veins (PVs) in patients with paroxysmal or persistent atrial fibrillation (PAF/PEAF) are encouraging. However, long-term outcomes are not well defined. Therefore, we evaluated 3–5-year outcomes in our series of patients. Freedom from symptomatic AF/flutter/tachycardia recurrences with patients off antiarrhythmic drugs (AAD) was considered a treatment success.
Methods: Consecutive patients with symptomatic PAF/PEAF and AAD failure, without significant structural heart disease, were prospectively recruited between September 2003 and November 2009. Irrigated-tip RF ablation catheter and Lasso catheter were used after standard trans-septal approach with X-ray fluoroscopic guidance. Ablation endpoints were: complete segmental/circumferential ostial and antral electrical PV isolation, non-PV foci ablation, and bi-directional flutter isthmus (FI) block when indicated. The procedure was repeated if AF/flutter/tachycardia recurred after 3-month blanking period. The suspected arrhythmia recurrences were evaluated by series of ECG/Holter recordings. Data were analyzed by t-, chi-square, and Fisher’s exact tests. P < 0.05 was considered statistically significant.
Results: In 126 patients, median age 55 years (range 19–75), 94 men (75 %), 86 with PAF and 40 with PEAF (31 %), 207 procedures were performed: single in 63 (50 %), double in 48 (38 %), and multiple in 15. FI was ablated in 53 patients (42 %). Tamponade occurred in 4 (3 %). No PV stenosis, esophageal injury, or stroke were detected clinically in 115 patients (91 %) during 36-month (13–89) follow-up. We achieved treatment success in 69 patients (61 %), partial success with a significant reduction of AF/flutter/tachycardia recurrences on AAD in 13 patients (12 %), and in 33 patients (27 %) the procedure was not successful. Overall, 73 % of our patients had long-term benefit. Outcomes were better in patients with PAF vs. PEAF (84 % vs. 48 %, p < 0,001), in younger age, in those without concomitant diseases, and in those with normal PV anatomy. These results were maintained in the subgroup of 58 patients over 56 months of follow-up: 35 (60 %), 6 (11 %), and 17 (29 %), respectively.
Conclusions: Lasso-guided RF irrigated-tip segmental/circumferential PV isolation is a safe and long-term successful treatment of PAF in the majority of our patients. The method needs improvements in patients with PEAF, possibly with the introduction of new technologies.
Downloads
References
Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns JG, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm 2007; 4: 816–61.
Ouyang F, Tilz RR, Julian Chun K-RJ, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010; 122: 2368–77.
Tzou WS, Marchlinski FE, Zado ES, Lin D, Dixit S, Callans DJ, et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 237–2.
Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J. Am Coll Cardiol 2011: 57: 160–6.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. Heart Rhythm. 2012: 9: 632–96.
Šinkovec M, Pernat A. Follow-up after lasso-guided irrigated tip radiofrequency catheter ablation in paroxismal and persistent atrial fibrillation. Zdrav Vestn 2009; 78: 457–61.
Miller MA, d‘Avila A, Dukkipati SR, Koruth JS, Viles-Gonzalez J, Napolitano C, et al. Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: the importance of closing the visual gap. Europace 2012; 14: 653–60.
Sy RW, Gula LJ, Leong-Sit P, Klein GJ, Yee R, Krahn AD, et al. Complete antral encirclement is not required for pulmonary vein isolation. Heart Rhythm 2011; 8: 16–22.
Hayward RM, Upadhyay GA, Mela T, Ellinor PT, Barrett CD, Heist EK, et al. Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis.Heart Rhythm 2011; 8: 994–1000.
Dixit S, Marchlinski FE, Callans DJ, Bala R, Riley MP, Garcia FC,Hutchinson MD, Ratcliffe SJ, Cooper JM, Verdino RJ, Patel VV, Zado ES, Cash NR,Killian T, Tomson TT, Gerstenfeld EP. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012; 5: 287–94.
Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634–40.
Jais P, Cauchemez B, Macle L Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498–2505.
Wilber DJ, Pappone C, Neuzil P De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303: 333–40.
Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009: 2; 349–61.
Weerasooriya R, Jais P, Le Heuzey JY, Scaveé C, Choi KJ, Macle L, et al. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2003; 26: 292–4.
Goldberg A, Menen M, Mickelsen S, MacIndoe C, Binder M, Nawman R, et al. Atrial fibrillation ablation leads to long–term improvement of quality of life and reduced utilization of healthcare resources. J Interv Card Electrophysiol 2003; 8: 59–64.
Chan PS, Vijan S, Morady F, Oral H. Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol 2006; 47: 2513–2520.
Khaykin Y, Wang X, Natale A, Wazni OM, Skanes AC, Humphries KH, et al. Cost comparison of ablation versus antiarrhythmic drugs as first--line therapy for atrial fibrillation: An economic evaluation of the RAAFT pilot study. J Cardiovasc Electrophysiol 2009; 20: 7–12.
Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010; 3: 615–623.
Patterson E, Lazzara R, Szabo B, Liu H, Tang D, Li YH, et al. Sodium-Calcium exchange initiated by the Ca2+ transient: An arrhythmia trigger within pulmonary veins. J Am Coll Cardiol 2006; 47: 1196–206
Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, et al. The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11: 3–20.
Raziskave CINDI o dejavnikih tveganja in učinkovitosti procesa. Izsledki raziskav Ljubljansko območje 2002/2003. Maučec Zakotnik J in sod., ur. Ljubljana: Inštitut za varovanje zdravja Republike Slovenije 2009: 4–170.
Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 2009; 53: 1798–1803.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
